These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 25961977)

  • 1. Are estradiol metabolites involved in gynaecological carcinogenesis?
    Seeger H; Mueck AO
    Horm Mol Biol Clin Investig; 2010 Jan; 1(3):111-6. PubMed ID: 25961977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer: are oestrogen metabolites carcinogenic?
    Mueck AO; Seeger H
    Maturitas; 2007 May; 57(1):42-6. PubMed ID: 17383836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Estrogen-dependent neoplasia - what is the significance of estradiol metabolites].
    Mueck AO; Seeger H; Lippert TH
    Zentralbl Gynakol; 2003 Nov; 125(11):458-66. PubMed ID: 14634875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of possible carcinogenic estradiol metabolites: effects on proliferation, apoptosis and metastasis of human breast cancer cells.
    Seeger H; Wallwiener D; Kraemer E; Mueck AO
    Maturitas; 2006 Apr; 54(1):72-7. PubMed ID: 16213115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estradiol metabolism during oral and transdermal estradiol replacement therapy in postmenopausal women.
    Lippert TH; Seeger H; Mueck AO
    Horm Metab Res; 1998 Sep; 30(9):598-600. PubMed ID: 9808331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen metabolite ratio: Is the 2-hydroxyestrone to 16α-hydroxyestrone ratio predictive for breast cancer?
    Obi N; Vrieling A; Heinz J; Chang-Claude J
    Int J Womens Health; 2011 Feb; 3():37-51. PubMed ID: 21339936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer risk during HRT: influence of estradiol metabolites on breast cancer and endothelial cell proliferation.
    Seeger H; Deuringer FU; Wallwiener D; Mueck AO
    Maturitas; 2004 Nov; 49(3):235-40. PubMed ID: 15488352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between physical activity and 2-hydroxyestrone, 16alpha-hydroxyestrone, and the 2/16 ratio in premenopausal women (United States).
    Bentz AT; Schneider CM; Westerlind KC
    Cancer Causes Control; 2005 May; 16(4):455-61. PubMed ID: 15953988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of estrogens and metabolites on endometrial carcinogenesis in young adult mice initiated with N-ethyl-N'-nitro-N-nitrosoguanidine.
    Takahashi M; Shimomoto T; Miyajima K; Yoshida M; Katashima S; Uematsu F; Maekawa A; Nakae D
    Cancer Lett; 2004 Jul; 211(1):1-9. PubMed ID: 15194211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis?
    Zhu BT; Conney AH
    Cancer Res; 1998 Jun; 58(11):2269-77. PubMed ID: 9622057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of multiplex endogenous estrogen metabolites in human urine using ultra-fast liquid chromatography-tandem mass spectrometry: a case study for breast cancer.
    Huang J; Sun J; Chen Y; Song Y; Dong L; Zhan Q; Zhang R; Abliz Z
    Anal Chim Acta; 2012 Jan; 711():60-8. PubMed ID: 22152797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new ELISA kit for measuring urinary 2-hydroxyestrone, 16alpha-hydroxyestrone, and their ratio: reproducibility, validity, and assay performance after freeze-thaw cycling and preservation by boric acid.
    Falk RT; Rossi SC; Fears TR; Sepkovic DW; Migella A; Adlercreutz H; Donaldson J; Bradlow HL; Ziegler RG
    Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):81-7. PubMed ID: 10667467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary estrogen metabolites and breast cancer: a case-control study.
    Kabat GC; Chang CJ; Sparano JA; Sepkovie DW; Hu XP; Khalil A; Rosenblatt R; Bradlow HL
    Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):505-9. PubMed ID: 9232337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of dietary soy isoflavone aglycones on the urinary 16alpha-to-2-hydroxyestrone ratio in C3H/HeJ mice.
    Kishida T; Beppu M; Nashiki K; Izumi T; Ebihara K
    Nutr Cancer; 2000; 38(2):209-14. PubMed ID: 11525599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of caspase-9 but not caspase-8 in the anti-apoptotic effects of estradiol and 4-OH-Estradiol in MCF-7 human breast cancer cells.
    Gregoraszczuk E; Ptak A
    Endocr Regul; 2011 Jan; 45(1):3-8. PubMed ID: 21314204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of flaxseed and wheat bran consumption on urinary estrogen metabolites in premenopausal women.
    Haggans CJ; Travelli EJ; Thomas W; Martini MC; Slavin JL
    Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):719-25. PubMed ID: 10919743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of flaxseed consumption on urinary levels of estrogen metabolites in postmenopausal women.
    Sturgeon SR; Volpe SL; Puleo E; Bertone-Johnson ER; Heersink J; Sabelawski S; Wahala K; Bigelow C; Kurzer MS
    Nutr Cancer; 2010; 62(2):175-80. PubMed ID: 20099191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of postmenopausal hormone replacement therapy and oral contraceptives on the endogenous estradiol metabolism.
    Mueck AO; Seeger H; Gräser T; Oettel M; Lippert TH
    Horm Metab Res; 2001 Dec; 33(12):744-7. PubMed ID: 11753761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary phytoestrogen excretion of rats bearing methylnitrosourea-induced mammary carcinoma in response to treatment with 2-methoxyestradiol.
    Lippert TH; Adlercreutz H; Berger MR; Seeger H; Mueck AO
    J Steroid Biochem Mol Biol; 2007 Feb; 103(2):158-62. PubMed ID: 17081745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of estradiol metabolites and progestogens on the proliferation of human ovarian cancer cells.
    Seeger H; Mueck AO
    Panminerva Med; 2006 Mar; 48(1):13-7. PubMed ID: 16633327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.